GFO Issue 51, Article Number: 4
Sub-title :
ABSTRACT
ABSTRACT
A detailed listing and analysis is provided of which Round 5 proposals have been approved.
Based on advise from the Technical Review Panel (TRP), the Board divides eligible proposals into five Categories, as follows:
- Category 1: Approved proposals requiring no or minor clarifications, which need to be provided within 4 weeks and then given a final approval by the TRP Chair and/or Vice-Chair.
- Category 2A: Proposals that are provisionally approved subject to the required clarifications being provided within a limited timeframe (6 weeks for the applicant to respond to the TRP queries, 4 months to obtain the final TRP approval should further clarifications be requested). The primary reviewer and secondary reviewer as well as TRP Chair and /or Vice-Chair need to give final approval.
- Category 2B: Similar to Category 2A, but regarded as relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation. The TRP took no account of the applicant country's income level, nor of burden of disease nor of any factors other than technical merit and feasibility in grading a proposal as Category 2B. In other words, these proposals differ from Category 2A proposals only in that they have more technical weaknesses, and/or more questions as to effective implementation, and/or more required clarifications. It is important to note, however, that on balance all of the Category 2B proposals were regarded as recommended for funding, and the TRP believes that the weaknesses and clarifications could be addressed within the timeframes provided for Category 2A proposals.
- Category 3: Not approved in their present form, but applicants are encouraged to submit an improved proposal in some future Round.
- Category 4: Rejected.
If the Fund had sufficient pledges for 2005 to cover the cost of all Category 1, 2A and 2B proposals, it would have approved all of them at last week's meeting, subject to the applicants responding acceptably to the TRP's requests for clarification that will be sent to the applicants.
However, given that the Fund currently has insufficient pledges to cover all the Category 1, 2A and 2B proposals, the board agreed to proceed as follows, using a procedure specified at an earlier board meeting:
- Category 1 proposals are approved.
- Category 2A and 2B proposals are given a "Composite Index" of between 1 and 8 points, as follows:
- If the country has a "very high" disease burden, it receives 4 points, and otherwise it receives 1 point.
- In addition, if the country is "low-income" it receives 4 points, and if it is "lower-middle income" it receives 2 points. ("Upper-middle income" countries receive 0 extra points.)
Proposals were ranked by Category and then, for Categories 2A and 2B, they were sub-ranked by Composite Index. This led to them being grouped as in Table 5, below.
The Fund currently has enough pledges to pay for the first three groups. These have been labeled by GFO as "Immediately Approved: A, B and C". Proposals that fall into these three groups are approved, subject to satisfactory responses being provided to the TRP queries.
The Fund does not currently have sufficient pledges to pay for proposals in the next eight groups, labeled by GFO as "Provisionally Approved D, E, F, G, H, I, J and K". When the Fund received pledges sufficient to cover each additional group (in the order shown below), the board will approve those proposals by email.
The Secretariat will start working immediately with all provisionally approved applicants on dealing with TRP queries and negotiating grant agreements. If all those activities have been completed before pledges and actual cash contributions have been received, the actual signing of grant agreements will have to be put on hold.
However, provisionally approved proposals for which insufficient pledges are received by the end of June 2006 will lose their provisional approval and will be treated as if they had not been approved.
Table 5: Round 5 results by Category
Decision
Explanation
Number of proposals
Budget
Years 1-2
Budget
Years 1-5
Immediately Approved: A
Category 1
5
$43,310,437
$98,935,651
Immediately Approved: B
Category 2A, Composite Index 8
18
$290,762,706
$728,609,400
Immediately Approved: C
Category 2A, Composite Index 6
3
$48,003,918
$149,563,776
Subtotal: All "Immediately Approved" proposals
26
$382,077,061
$977,108,827
Provisionally approved: D
Category 2A, Composite Index 5
12
$133,276,403
$345,346,815
Provisionally approved: E
Category 2A, Composite Index 4
2
$9,529,070
$24,888,718
Provisionally approved: F
Category 2A, Composite Index 3
13
$92,575,047
$165,266,161
Provisionally approved: G
Category 2B, Composite Index 8
4
$87,358,034
$207,352,569
Provisionally approved: H
Category 2B, Composite Index 7
1
$3,269,731
$6,623,560
Provisionally approved: I
Category 2B, Composite Index 6
1
$6,501,141
$21,232,348
Provisionally approved: J
Category 2B, Composite Index 5
2
$3,356,219
$6,868,700
Provisionally approved: K
Category 2B, Composite Index 3
2
$7,673,482
$19,814,848
Subtotal: All "Provisionally Approved" proposals
37
$343,539,127
$797,393,719
Total: All "Immediately Approved" plus "Provisionally Approved" proposals
63
$725,616,188
$1,774,502,546
Not approved: L
Category 3
120
$2,266,242,296
$5,096,656,571
Not approved: M
Category 4
19
$306,210,534
$750,510,205
Subtotal: All "Not Approved" proposals
139
$2,572,452,830
$5,847,166,776
GRAND TOTAL
202
$3,298,069,018
$7,621,669,322
Table 6: Round 5 results by country
Country
Applicant
Decision
(See definitions above)
Component
Budget
Years 1-2
Budget
Years 1-5
Afghanistan
CCM
Provisionally approved: D
Malaria
$17,093,334
$32,214,069
Afghanistan
CCM
Not approved: L
HIV/AIDS
$4,663,653
$10,953,024
Afghanistan
CCM
Not approved: L
HSS
$1,980,090
$4,014,470
Albania
CCM
Provisionally approved: F
HIV/AIDS
$2,502,858
$4,990,645
Albania
CCM
Provisionally approved: F
TB
$877,685
$1,442,028
Angola
CCM
Not approved: L
Malaria
$39,227,228
$115,827,277
Armenia
CCM
Provisionally approved: K
TB
$3,898,656
$7,624,135
Armenia
CCM
Not approved: M
Malaria
$1,705,100
$2,572,700
Azerbaijan
CCM
Immediately Approved: A
TB
$3,825,770
$9,516,200
Azerbaijan
CCM
Not approved: L
Malaria
$3,179,532
$7,255,952
Bangladesh
CCM
Immediately Approved: B
TB
$10,003,984
$45,977,231
Bangladesh
CCM
Not approved: L
HIV/AIDS
$8,135,641
$23,901,394
Bangladesh
CCM
Not approved: L
Malaria
$18,478,606
$36,993,988
Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka
Regional CM
Not approved: M
HIV/AIDS
$15,464,067
$59,842,897
Belarus
CCM
Not approved: L
TB
$13,239,086
$26,389,516
Benin
CCM
Provisionally approved: D
HIV/AIDS
$19,709,054
$51,841,972
Benin
CCM
Not approved: L
HSS
$6,560,978
$12,130,576
Benin
CCM
Not approved: L
Malaria
$10,714,920
$52,930,467
Benin
CCM
Not approved: L
TB
$3,575,918
$7,793,321
Benin, Cote d'Ivoire, Ethiopia, Nigeria, Zimbabwe
Regional org. (PSI and African Union)
Not approved: M
HIV/AIDS
$17,304,394
$44,804,606
Bosnia Herzegovina
CCM
Provisionally approved: F
HIV/AIDS
$4,832,387
$11,042,257
Bosnia Herzegovina
CCM
Not approved: L
TB
$1,171,290
$3,157,230
Botswana
CCM
Provisionally approved: E
TB
$5,515,900
$8,956,258
Brazil
CCM
Immediately Approved: C
TB
$11,602,427
$27,240,000
Burkina Faso
CCM
Not approved: L
HIV/AIDS
$34,432,357
$71,569,383
Burkina Faso
CCM
Not approved: L
HSS
$5,845,718
$9,170,885
Burkina Faso
CCM
Not approved: L
Malaria
$19,208,881
$27,152,602
Burundi
CCM
Provisionally approved: G
HIV/AIDS
$13,053,866
$32,353,173
Burundi
CCM
Not approved: L
HSS
$2,370,296
$6,566,203
Burundi
CCM
Not approved: L
Malaria
$12,215,162
$25,401,464
Cambodia
CCM
Immediately Approved: B
TB
$3,268,750
$9,662,024
Cambodia
CCM
Provisionally approved: D
HIV/AIDS
$16,292,779
$34,963,654
Cambodia
CCM
Provisionally approved: G
HSS
$1,841,600
$5,015,741
Cambodia
CCM
Not approved: L
Malaria
$5,854,119
$11,824,545
Cameroon
CCM
Immediately Approved: B
HIV/AIDS
$4,943,590
$12,060,019
Cameroon
CCM
Immediately Approved: B
Malaria
$12,695,885
$21,210,595
Cape Verde
CCM
Not approved: L
HIV/AIDS
$4,313,270
$11,659,200
Central African Republic
CCM
Not approved: L
HIV/AIDS
$22,082,191
$36,632,357
Central African Republic
CCM
Not approved: L
Malaria
$7,598,940
$11,990,390
Chad
CCM
Not approved: L
Malaria
$17,335,833
$36,713,126
China
CCM
Immediately Approved: C
TB
$17,814,000
$52,889,000
China
CCM
Provisionally approved: F
HIV/AIDS
$12,544,128
$28,902,074
China
CCM
Provisionally approved: F
Malaria
$20,096,149
$39,410,395
Colombia
CCM
Not approved: L
HIV/AIDS
$13,338,388
$29,356,545
Comoros
CCM
Not approved: L
Malaria
$4,110,188
$7,727,600
Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama
Regional org. (Secretary of Social Integration of Central America - SSICA)
Not approved: M
HIV/AIDS
$13,859,280
$30,722,300
Cote d'Ivoire
Non-CCM (CARE)
Immediately Approved: B
HIV/AIDS
$3,522,695
$3,522,695
Cote d'Ivoire
CCM
Not approved: L
HIV/AIDS
$26,836,531
$47,022,390
Cote d'Ivoire
CCM
Not approved: L
Malaria
$7,897,631
$20,272,415
Dem. Rep. Congo
CCM
Immediately Approved: B
TB
$17,613,606
$43,716,984
Dem. Rep. Congo
CCM
Not approved: L
HIV/AIDS
$60,848,374
$142,154,402
Dem. Rep. Congo
CCM
Not approved: L
HSS
$17,947,453
$40,244,494
Dem. Rep. Congo
CCM
Not approved: L
Malaria
$21,184,713
$38,608,576
Dem. Rep. Congo - Kasai
Sub-CCM
Not approved: M
HIV/AIDS
$66,831,110
$127,046,138
Dem. Rep. Congo - Kasai
Sub-CCM
Not approved: M
Malaria
$16,564,000
$29,779,000
Dem. Rep. Congo - Kasai
Sub-CCM
Not approved: M
TB
$12,702,000
$23,507,000
Djibouti
CCM
Not approved: L
Malaria
$2,344,000
$5,113,000
Djibouti
CCM
Not approved: L
TB
$4,819,773
$10,704,374
Dominican Republic
CCM
Not approved: L
Malaria
$5,368,399
$11,914,220
East Timor
CCM
Provisionally approved: D
HIV/AIDS
$4,304,454
$9,110,302
Ecuador
CCM
Not approved: L
Malaria
$4,097,749
$4,097,749
Egypt
CCM
Not approved: L
HIV/AIDS
$2,185,934
$6,201,772
Egypt
CCM
Not approved: L
TB
$4,588,252
$11,085,278
Egypt
CCM
Not approved: M
Malaria
$2,380,000
$5,000,000
El Salvador
CCM
Not approved: L
Malaria
$1,100,000
$3,000,000
Equatorial Guinea
CCM
Not approved: L
Malaria
$12,906,111
$25,999,072
Eritrea
CCM
Provisionally approved: D
HIV/AIDS
$13,139,010
$33,892,005
Eritrea
CCM
Not approved: L
HSS
$7,697,965
$14,435,485
Eritrea
CCM
Not approved: L
Malaria
$8,844,992
$17,200,208
Eritrea
CCM
Not approved: L
TB
$1,443,404
$3,879,324
Ethiopia
CCM
Provisionally approved: G
Malaria
$64,548,913
$150,066,528
Ethiopia
CCM
Not approved: L
HIV/AIDS
$23,145,990
$64,497,352
Ethiopia
CCM
Not approved: L
HSS
$159,999,343
$348,014,355
Ethiopia
CCM
Not approved: L
TB
$16,440,576
$69,882,371
Gabon
CCM
Provisionally approved: E
Malaria
$4,013,170
$15,932,460
Georgia
CCM
Not approved: L
HIV/AIDS
$2,797,640
$4,654,240
Georgia
CCM
Not approved: L
HSS
$436,320
$814,320
Ghana
CCM
Immediately Approved: A
TB
$14,547,546
$31,471,844
Ghana
CCM
Provisionally approved: D
HIV/AIDS
$31,630,830
$97,099,610
Ghana
CCM
Not approved: L
HSS
$12,552,761
$19,359,341
Ghana, Uganda, Zimbabwe
Regional org. (TEPHINET)
Not approved: M
HSS
$16,363,767
$36,318,213
Guatemala
CCM
Not approved: L
TB
$5,826,331
$11,623,999
Guinea
CCM
Immediately Approved: A
TB
$3,391,501
$6,225,144
Guinea
CCM
Not approved: L
Malaria
$3,467,563
$18,987,568
Haiti
CCM
Immediately Approved: B
HIV/AIDS
$19,205,567
$49,927,069
India
CCM
Not approved: L
Malaria
$14,742,454
$26,448,410
India
CCM
Not approved: L
TB
$7,410,000
$25,020,000
India
CCM
Not approved: M
HIV/AIDS
$67,620,403
$217,625,981
Indonesia
CCM
Immediately Approved: C
TB
$18,587,491
$69,434,776
Indonesia
CCM
Not approved: L
HIV/AIDS
$13,671,879
$26,117,640
Indonesia
CCM
Not approved: L
Malaria
$43,145,932
$66,543,849
Iran
CCM
Not approved: L
Malaria
$8,500,000
$18,600,000
Jordan
CCM
Provisionally approved: F
TB
$1,072,864
$2,782,864
Jordan
CCM
Not approved: L
HIV/AIDS
$3,588,958
$6,899,718
Kazakhstan
CCM
Not approved: L
HIV/AIDS
$2,000,295
$4,814,539
Kazakhstan
CCM
Not approved: L
TB
$8,375,651
$17,558,542
Kenya
CCM
Provisionally approved: G
TB
$7,913,655
$19,917,127
Kenya
CCM
Not approved: L
HIV/AIDS
$8,893,681
$19,796,832
Kenya
CCM
Not approved: L
HSS
$11,179,083
$28,076,553
Kenya
CCM
Not approved: L
Malaria
$4,230,600
$8,427,600
Kosovo
CCM
Not approved: L
HIV/AIDS
$1,701,158
$3,687,350
Kyrgyzstan
CCM
Provisionally approved: D
Malaria
$1,692,390
$3,426,125
Kyrgyzstan
CCM
Not approved: L
TB
$5,309,127
$8,863,698
Lesotho
CCM
Immediately Approved: B
HIV/AIDS
$10,013,383
$40,346,059
Liberia
CCM
Not approved: L
HIV/AIDS
$12,394,177
$25,714,627
Liberia
CCM
Not approved: L
HSS
$14,078,615
$17,374,573
Liberia
CCM
Not approved: L
Malaria
$15,015,748
$33,165,706
Liberia
CCM
Not approved: L
TB
$4,750,966
$11,949,773
Macedonia
CCM
Provisionally approved: F
TB
$1,442,489
$3,071,097
Madagascar
CCM
Not approved: L
HIV/AIDS
$9,512,412
$24,957,422
Madagascar
CCM
Not approved: L
HSS
$4,965,759
$22,599,312
Madagascar
CCM
Not approved: L
Malaria
$7,974,500
$33,470,801
Madagascar
CCM
Not approved: L
TB
$8,900,519
$15,249,703
Malawi
CCM
Immediately Approved: B
HIV/AIDS
$7,770,655
$19,104,775
Malawi
CCM
Immediately Approved: B
HSS
$26,965,524
$65,429,986
Maldives
CCM
Not approved: M
HIV/AIDS
$2,016,601
$4,184,665
Mali
CCM
Not approved: L
HSS
$7,083,766
$11,600,785
Mali
CCM
Not approved: L
Malaria
$14,862,149
$36,069,482
Mauritania
CCM
Provisionally approved: D
HIV/AIDS
$6,584,973
$15,755,931
Mongolia
CCM
Provisionally approved: D
HIV/AIDS
$1,898,775
$4,235,640
Montenegro
CCM
Provisionally approved: F
HIV/AIDS
$1,604,606
$2,924,696
Mozambique
CCM
Not approved: L
HSS
$72,100,000
$106,600,000
Mozambique
CCM
Not approved: L
Malaria
$32,694,480
$73,121,487
Mozambique, South Africa, Swaziland
Regional CM
Provisionally approved: I
Malaria
$6,501,141
$21,232,348
Namibia
CCM
Immediately Approved: A
TB
$7,222,753
$17,777,383
Namibia
CCM
Not approved: L
HIV/AIDS
$31,341,874
$91,950,544
Namibia
CCM
Not approved: L
Malaria
$13,136,240
$21,897,490
Nepal
CCM
Not approved: L
HIV/AIDS
$7,717,233
$25,788,007
Nepal
CCM
Not approved: L
Malaria
$5,352,822
$11,372,370
Nepal
CCM
Not approved: L
TB
$3,858,926
$9,481,273
Niger
CCM
Immediately Approved: B
Malaria
$5,148,600
$10,491,196
Niger
CCM
Provisionally approved: D
TB
$6,326,070
$12,220,815
Niger
CCM
Not approved: L
HSS
$7,529,467
$11,474,188
Nigeria
CCM
Immediately Approved: B
HIV/AIDS
$46,424,283
$180,642,512
Nigeria
CCM
Immediately Approved: B
TB
$19,217,311
$53,351,149
Nigeria
CCM
Not approved: L
HSS
$39,505,341
$64,812,236
Nigeria
CCM
Not approved: L
Malaria
$52,404,797
$179,995,004
Pakistan
CCM
Not approved: L
HIV/AIDS
$13,000,477
$34,989,566
Pakistan
CCM
Not approved: L
Malaria
$11,293,294
$27,059,519
Pakistan
CCM
Not approved: L
TB
$15,854,040
$30,308,701
Pakistan
CCM
Not approved: M
HSS
$9,977,880
$26,617,490
Papua New Guinea
CCM
Not approved: L
TB
$1,975,954
$10,784,888
Paraguay
CCM
Not approved: M
HIV/AIDS
$3,941,134
$9,429,262
Peru
CCM
Provisionally approved: F
HIV/AIDS
$9,874,896
$12,967,865
Peru
CCM
Provisionally approved: F
TB
$21,017,537
$32,545,545
Peru
CCM
Not approved: L
HSS
$6,894,200
$17,011,200
Philippines
CCM
Provisionally approved: F
HIV/AIDS
$3,011,919
$6,478,058
Philippines
CCM
Provisionally approved: F
Malaria
$11,097,529
$14,308,637
Philippines
CCM
Not approved: L
TB
$14,208,812
$45,817,584
Republic of Congo
CCM
Provisionally approved: D
HIV/AIDS
$12,043,407
$45,553,763
Republic of Congo
CCM
Not approved: L
Malaria
$17,664,123
$28,331,791
Republic of Congo
CCM
Not approved: L
TB
$4,669,340
$8,138,467
Russian Federation
Non-CCM
Provisionally approved: K
HIV/AIDS
$3,774,826
$12,190,713
Rwanda
CCM
Immediately Approved: A
HSS
$14,322,867
$33,945,080
Rwanda
CCM
Immediately Approved: B
Malaria
$28,140,772
$39,649,363
Rwanda
CCM
Not approved: L
HIV/AIDS
$36,053,491
$88,300,796
Samoa, Cook Islands, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, Niue, Palau, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu
Regional Coordinating Mechanism
Not approved: L
HIV/AIDS
$4,251,406
$9,946,332
Samoa, Cook Islands, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, Niue, Palau, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu
Regional Coordinating Mechanism
Not approved: L
TB
$1,466,940
$4,432,060
Sao Tome & Principe
CCM
Provisionally approved: J
HIV/AIDS
$584,218
$1,485,190
Senegal
CCM
Not approved: L
TB
$8,725,379
$18,336,573
Senegal
CCM
Not approved: M
HSS
$2,321,013
$3,384,233
Senegal
CCM
Not approved: M
Malaria
$8,251,057
$12,117,141
Serbia
CCM
Not approved: L
HIV/AIDS
$4,755,306
$8,462,528
Solomon Islands, Vanuatu
Regional Coordinating Mechanism
Provisionally approved: H
Malaria
$3,269,731
$6,623,560
Somalia
Non-CCM
Not approved: L
HSS
$1,175,365
$2,832,730
Somalia
Non-CCM
Not approved: L
Malaria
$2,567,445
$14,532,272
South Africa
CCM
Not approved: L
HIV/AIDS
$45,010,000
$108,289,000
South Africa
CCM
Not approved: L
HSS
$21,851,000
$42,173,000
Sri Lanka
CCM
Not approved: L
Malaria
$4,356,374
$7,290,124
Sri Lanka
CCM
Not approved: L
TB
$1,700,680
$4,414,795
Sri Lanka
CCM
Not approved: M
HIV/AIDS
$2,607,594
$5,357,285
Sudan
CCM
Not approved: L
HIV/AIDS
$29,424,335
$112,553,275
Sudan
CCM
Not approved: L
Malaria
$24,019,599
$46,323,995
Sudan
CCM
Not approved: L
TB
$6,830,013
$15,410,468
Sudan
CCM
Not approved: M
HSS
$42,800,000
$105,860,000
Sudan (Southern Sector)
Sub-CCM
Immediately Approved: B
TB
$8,592,197
$27,568,526
Sudan (Southern Sector)
Sub-CCM
Not approved: L
HSS
$25,929,249
$68,455,557
Suriname
CCM
Provisionally approved: F
HIV/AIDS
$2,600,000
$4,400,000
Tajikistan
CCM
Provisionally approved: J
Malaria
$2,772,001
$5,383,510
Tanzania
CCM
Not approved: L
HIV/AIDS
$9,204,276
$11,932,883
Tanzania
CCM
Not approved: L
HSS
$22,869,642
$34,866,750
Tanzania Zanzibar
CCM
Not approved: L
HIV/AIDS
$12,722,287
$30,817,709
Thailand
CCM
Not approved: L
HIV/AIDS
$5,920,079
$16,886,287
The Gambia
CCM
Provisionally approved: D
TB
$2,561,327
$5,032,929
The Gambia
CCM
Not approved: L
HIV/AIDS
$7,842,275
$14,733,869
The Gambia
CCM
Not approved: L
Malaria
$18,169,122
$40,473,141
Tunisia
CCM
Not approved: L
HIV/AIDS
$10,007,400
$20,898,000
Turkey
CCM
Not approved: M
Malaria
$2,387,990
$4,784,490
Turkey
CCM
Not approved: M
TB
$1,113,144
$1,556,804
Uganda
CCM
Not approved: L
HIV/AIDS
$5,857,397
$17,746,651
Uganda
CCM
Not approved: L
HSS
$5,605,994
$10,942,316
Uganda
CCM
Not approved: L
Malaria
$49,494,235
$90,219,700
Vietnam
CCM
Not approved: L
HIV/AIDS
$6,500,000
$20,000,000
Vietnam
CCM
Not approved: L
TB
$7,037,112
$18,718,344
Yemen
CCM
Not approved: L
Malaria
$15,889,956
$41,763,366
Zambia
CCM
Not approved: L
HIV/AIDS
$481,308,000
$1,033,420,000
Zambia
CCM
Not approved: L
HSS
$11,042,000
$34,940,000
Zambia
CCM
Not approved: L
Malaria
$22,147,000
$41,200,000
Zambia
CCM
Not approved: L
TB
$98,610,000
$246,525,000
Zimbabwe
CCM
Immediately Approved: B
HIV/AIDS
$35,931,159
$62,478,891
Zimbabwe
CCM
Immediately Approved: B
Malaria
$21,217,469
$29,998,400
Zimbabwe
CCM
Immediately Approved: B
TB
$10,087,276
$13,471,926
Information on Round 5 grants is also available on the Global Fund web site at www.theglobalfund.org/en/about/board/eleventh.
An applicant may appeal the board's decision if the applicant submitted an eligible proposal for a particular component in both Round 4 and Round 5 and was not approved in either case. The appeal must show that the recommendation made by the TRP regarding the Round 5 proposal was based on a "significant and obvious" error. The appeal must be filed with the Secretariat no later than 28 days from when the applicant receives written notice of the board's Round 5 decision. For further details regarding the appeals procedure, see www.theglobalfund.org/en/apply/proposals/appeals.
- Category 1: Approved proposals requiring no or minor clarifications, which need to be provided within 4 weeks and then given a final approval by the TRP Chair and/or Vice-Chair.
- Category 2A: Proposals that are provisionally approved subject to the required clarifications being provided within a limited timeframe (6 weeks for the applicant to respond to the TRP queries, 4 months to obtain the final TRP approval should further clarifications be requested). The primary reviewer and secondary reviewer as well as TRP Chair and /or Vice-Chair need to give final approval.
- Category 2B: Similar to Category 2A, but regarded as relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation. The TRP took no account of the applicant country's income level, nor of burden of disease nor of any factors other than technical merit and feasibility in grading a proposal as Category 2B. In other words, these proposals differ from Category 2A proposals only in that they have more technical weaknesses, and/or more questions as to effective implementation, and/or more required clarifications. It is important to note, however, that on balance all of the Category 2B proposals were regarded as recommended for funding, and the TRP believes that the weaknesses and clarifications could be addressed within the timeframes provided for Category 2A proposals.
- Category 3: Not approved in their present form, but applicants are encouraged to submit an improved proposal in some future Round.
- Category 4: Rejected.
- Category 1 proposals are approved.
- Category 2A and 2B proposals are given a "Composite Index" of between 1 and 8 points, as follows:
- If the country has a "very high" disease burden, it receives 4 points, and otherwise it receives 1 point.
- In addition, if the country is "low-income" it receives 4 points, and if it is "lower-middle income" it receives 2 points. ("Upper-middle income" countries receive 0 extra points.)
| Decision | Explanation | Number of proposals | Budget Years 1-2 | Budget Years 1-5 |
| Immediately Approved: A | Category 1 | 5 | $43,310,437 | $98,935,651 |
| Immediately Approved: B | Category 2A, Composite Index 8 | 18 | $290,762,706 | $728,609,400 |
| Immediately Approved: C | Category 2A, Composite Index 6 | 3 | $48,003,918 | $149,563,776 |
| Subtotal: All "Immediately Approved" proposals | 26 | $382,077,061 | $977,108,827 | |
| Provisionally approved: D | Category 2A, Composite Index 5 | 12 | $133,276,403 | $345,346,815 |
| Provisionally approved: E | Category 2A, Composite Index 4 | 2 | $9,529,070 | $24,888,718 |
| Provisionally approved: F | Category 2A, Composite Index 3 | 13 | $92,575,047 | $165,266,161 |
| Provisionally approved: G | Category 2B, Composite Index 8 | 4 | $87,358,034 | $207,352,569 |
| Provisionally approved: H | Category 2B, Composite Index 7 | 1 | $3,269,731 | $6,623,560 |
| Provisionally approved: I | Category 2B, Composite Index 6 | 1 | $6,501,141 | $21,232,348 |
| Provisionally approved: J | Category 2B, Composite Index 5 | 2 | $3,356,219 | $6,868,700 |
| Provisionally approved: K | Category 2B, Composite Index 3 | 2 | $7,673,482 | $19,814,848 |
| Subtotal: All "Provisionally Approved" proposals | 37 | $343,539,127 | $797,393,719 | |
| Total: All "Immediately Approved" plus "Provisionally Approved" proposals | 63 | $725,616,188 | $1,774,502,546 | |
| Not approved: L | Category 3 | 120 | $2,266,242,296 | $5,096,656,571 |
| Not approved: M | Category 4 | 19 | $306,210,534 | $750,510,205 |
| Subtotal: All "Not Approved" proposals | 139 | $2,572,452,830 | $5,847,166,776 | |
| GRAND TOTAL | 202 | $3,298,069,018 | $7,621,669,322 |
|
Country |
Applicant |
Decision (See definitions above) |
Component |
Budget Years 1-2 |
Budget Years 1-5 |
| Afghanistan | CCM | Provisionally approved: D | Malaria |
$17,093,334 |
$32,214,069 |
| Afghanistan | CCM | Not approved: L | HIV/AIDS |
$4,663,653 |
$10,953,024 |
| Afghanistan | CCM | Not approved: L | HSS |
$1,980,090 |
$4,014,470 |
| Albania | CCM | Provisionally approved: F | HIV/AIDS |
$2,502,858 |
$4,990,645 |
| Albania | CCM | Provisionally approved: F | TB |
$877,685 |
$1,442,028 |
| Angola | CCM | Not approved: L | Malaria |
$39,227,228 |
$115,827,277 |
| Armenia | CCM | Provisionally approved: K | TB |
$3,898,656 |
$7,624,135 |
| Armenia | CCM | Not approved: M | Malaria |
$1,705,100 |
$2,572,700 |
| Azerbaijan | CCM | Immediately Approved: A | TB |
$3,825,770 |
$9,516,200 |
| Azerbaijan | CCM | Not approved: L | Malaria |
$3,179,532 |
$7,255,952 |
| Bangladesh | CCM | Immediately Approved: B | TB |
$10,003,984 |
$45,977,231 |
| Bangladesh | CCM | Not approved: L | HIV/AIDS |
$8,135,641 |
$23,901,394 |
| Bangladesh | CCM | Not approved: L | Malaria |
$18,478,606 |
$36,993,988 |
| Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka | Regional CM | Not approved: M | HIV/AIDS |
$15,464,067 |
$59,842,897 |
| Belarus | CCM | Not approved: L | TB |
$13,239,086 |
$26,389,516 |
| Benin | CCM | Provisionally approved: D | HIV/AIDS |
$19,709,054 |
$51,841,972 |
| Benin | CCM | Not approved: L | HSS |
$6,560,978 |
$12,130,576 |
| Benin | CCM | Not approved: L | Malaria |
$10,714,920 |
$52,930,467 |
| Benin | CCM | Not approved: L | TB |
$3,575,918 |
$7,793,321 |
| Benin, Cote d'Ivoire, Ethiopia, Nigeria, Zimbabwe | Regional org. (PSI and African Union) | Not approved: M | HIV/AIDS |
$17,304,394 |
$44,804,606 |
| Bosnia Herzegovina | CCM | Provisionally approved: F | HIV/AIDS |
$4,832,387 |
$11,042,257 |
| Bosnia Herzegovina | CCM | Not approved: L | TB |
$1,171,290 |
$3,157,230 |
| Botswana | CCM | Provisionally approved: E | TB |
$5,515,900 |
$8,956,258 |
| Brazil | CCM | Immediately Approved: C | TB |
$11,602,427 |
$27,240,000 |
| Burkina Faso | CCM | Not approved: L | HIV/AIDS |
$34,432,357 |
$71,569,383 |
| Burkina Faso | CCM | Not approved: L | HSS |
$5,845,718 |
$9,170,885 |
| Burkina Faso | CCM | Not approved: L | Malaria |
$19,208,881 |
$27,152,602 |
| Burundi | CCM | Provisionally approved: G | HIV/AIDS |
$13,053,866 |
$32,353,173 |
| Burundi | CCM | Not approved: L | HSS |
$2,370,296 |
$6,566,203 |
| Burundi | CCM | Not approved: L | Malaria |
$12,215,162 |
$25,401,464 |
| Cambodia | CCM | Immediately Approved: B | TB |
$3,268,750 |
$9,662,024 |
| Cambodia | CCM | Provisionally approved: D | HIV/AIDS |
$16,292,779 |
$34,963,654 |
| Cambodia | CCM | Provisionally approved: G | HSS |
$1,841,600 |
$5,015,741 |
| Cambodia | CCM | Not approved: L | Malaria |
$5,854,119 |
$11,824,545 |
| Cameroon | CCM | Immediately Approved: B | HIV/AIDS |
$4,943,590 |
$12,060,019 |
| Cameroon | CCM | Immediately Approved: B | Malaria |
$12,695,885 |
$21,210,595 |
| Cape Verde | CCM | Not approved: L | HIV/AIDS |
$4,313,270 |
$11,659,200 |
| Central African Republic | CCM | Not approved: L | HIV/AIDS |
$22,082,191 |
$36,632,357 |
| Central African Republic | CCM | Not approved: L | Malaria |
$7,598,940 |
$11,990,390 |
| Chad | CCM | Not approved: L | Malaria |
$17,335,833 |
$36,713,126 |
| China | CCM | Immediately Approved: C | TB |
$17,814,000 |
$52,889,000 |
| China | CCM | Provisionally approved: F | HIV/AIDS |
$12,544,128 |
$28,902,074 |
| China | CCM | Provisionally approved: F | Malaria |
$20,096,149 |
$39,410,395 |
| Colombia | CCM | Not approved: L | HIV/AIDS |
$13,338,388 |
$29,356,545 |
| Comoros | CCM | Not approved: L | Malaria |
$4,110,188 |
$7,727,600 |
| Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama | Regional org. (Secretary of Social Integration of Central America - SSICA) | Not approved: M | HIV/AIDS |
$13,859,280 |
$30,722,300 |
| Cote d'Ivoire | Non-CCM (CARE) | Immediately Approved: B | HIV/AIDS |
$3,522,695 |
$3,522,695 |
| Cote d'Ivoire | CCM | Not approved: L | HIV/AIDS |
$26,836,531 |
$47,022,390 |
| Cote d'Ivoire | CCM | Not approved: L | Malaria |
$7,897,631 |
$20,272,415 |
| Dem. Rep. Congo | CCM | Immediately Approved: B | TB |
$17,613,606 |
$43,716,984 |
| Dem. Rep. Congo | CCM | Not approved: L | HIV/AIDS |
$60,848,374 |
$142,154,402 |
| Dem. Rep. Congo | CCM | Not approved: L | HSS |
$17,947,453 |
$40,244,494 |
| Dem. Rep. Congo | CCM | Not approved: L | Malaria |
$21,184,713 |
$38,608,576 |
| Dem. Rep. Congo - Kasai | Sub-CCM | Not approved: M | HIV/AIDS |
$66,831,110 |
$127,046,138 |
| Dem. Rep. Congo - Kasai | Sub-CCM | Not approved: M | Malaria |
$16,564,000 |
$29,779,000 |
| Dem. Rep. Congo - Kasai | Sub-CCM | Not approved: M | TB |
$12,702,000 |
$23,507,000 |
| Djibouti | CCM | Not approved: L | Malaria |
$2,344,000 |
$5,113,000 |
| Djibouti | CCM | Not approved: L | TB |
$4,819,773 |
$10,704,374 |
| Dominican Republic | CCM | Not approved: L | Malaria |
$5,368,399 |
$11,914,220 |
| East Timor | CCM | Provisionally approved: D | HIV/AIDS |
$4,304,454 |
$9,110,302 |
| Ecuador | CCM | Not approved: L | Malaria |
$4,097,749 |
$4,097,749 |
| Egypt | CCM | Not approved: L | HIV/AIDS |
$2,185,934 |
$6,201,772 |
| Egypt | CCM | Not approved: L | TB |
$4,588,252 |
$11,085,278 |
| Egypt | CCM | Not approved: M | Malaria |
$2,380,000 |
$5,000,000 |
| El Salvador | CCM | Not approved: L | Malaria |
$1,100,000 |
$3,000,000 |
| Equatorial Guinea | CCM | Not approved: L | Malaria |
$12,906,111 |
$25,999,072 |
| Eritrea | CCM | Provisionally approved: D | HIV/AIDS |
$13,139,010 |
$33,892,005 |
| Eritrea | CCM | Not approved: L | HSS |
$7,697,965 |
$14,435,485 |
| Eritrea | CCM | Not approved: L | Malaria |
$8,844,992 |
$17,200,208 |
| Eritrea | CCM | Not approved: L | TB |
$1,443,404 |
$3,879,324 |
| Ethiopia | CCM | Provisionally approved: G | Malaria |
$64,548,913 |
$150,066,528 |
| Ethiopia | CCM | Not approved: L | HIV/AIDS |
$23,145,990 |
$64,497,352 |
| Ethiopia | CCM | Not approved: L | HSS |
$159,999,343 |
$348,014,355 |
| Ethiopia | CCM | Not approved: L | TB |
$16,440,576 |
$69,882,371 |
| Gabon | CCM | Provisionally approved: E | Malaria |
$4,013,170 |
$15,932,460 |
| Georgia | CCM | Not approved: L | HIV/AIDS |
$2,797,640 |
$4,654,240 |
| Georgia | CCM | Not approved: L | HSS |
$436,320 |
$814,320 |
| Ghana | CCM | Immediately Approved: A | TB |
$14,547,546 |
$31,471,844 |
| Ghana | CCM | Provisionally approved: D | HIV/AIDS |
$31,630,830 |
$97,099,610 |
| Ghana | CCM | Not approved: L | HSS |
$12,552,761 |
$19,359,341 |
| Ghana, Uganda, Zimbabwe | Regional org. (TEPHINET) | Not approved: M | HSS |
$16,363,767 |
$36,318,213 |
| Guatemala | CCM | Not approved: L | TB |
$5,826,331 |
$11,623,999 |
| Guinea | CCM | Immediately Approved: A | TB |
$3,391,501 |
$6,225,144 |
| Guinea | CCM | Not approved: L | Malaria |
$3,467,563 |
$18,987,568 |
| Haiti | CCM | Immediately Approved: B | HIV/AIDS |
$19,205,567 |
$49,927,069 |
| India | CCM | Not approved: L | Malaria |
$14,742,454 |
$26,448,410 |
| India | CCM | Not approved: L | TB |
$7,410,000 |
$25,020,000 |
| India | CCM | Not approved: M | HIV/AIDS |
$67,620,403 |
$217,625,981 |
| Indonesia | CCM | Immediately Approved: C | TB |
$18,587,491 |
$69,434,776 |
| Indonesia | CCM | Not approved: L | HIV/AIDS |
$13,671,879 |
$26,117,640 |
| Indonesia | CCM | Not approved: L | Malaria |
$43,145,932 |
$66,543,849 |
| Iran | CCM | Not approved: L | Malaria |
$8,500,000 |
$18,600,000 |
| Jordan | CCM | Provisionally approved: F | TB |
$1,072,864 |
$2,782,864 |
| Jordan | CCM | Not approved: L | HIV/AIDS |
$3,588,958 |
$6,899,718 |
| Kazakhstan | CCM | Not approved: L | HIV/AIDS |
$2,000,295 |
$4,814,539 |
| Kazakhstan | CCM | Not approved: L | TB |
$8,375,651 |
$17,558,542 |
| Kenya | CCM | Provisionally approved: G | TB |
$7,913,655 |
$19,917,127 |
| Kenya | CCM | Not approved: L | HIV/AIDS |
$8,893,681 |
$19,796,832 |
| Kenya | CCM | Not approved: L | HSS |
$11,179,083 |
$28,076,553 |
| Kenya | CCM | Not approved: L | Malaria |
$4,230,600 |
$8,427,600 |
| Kosovo | CCM | Not approved: L | HIV/AIDS |
$1,701,158 |
$3,687,350 |
| Kyrgyzstan | CCM | Provisionally approved: D | Malaria |
$1,692,390 |
$3,426,125 |
| Kyrgyzstan | CCM | Not approved: L | TB |
$5,309,127 |
$8,863,698 |
| Lesotho | CCM | Immediately Approved: B | HIV/AIDS |
$10,013,383 |
$40,346,059 |
| Liberia | CCM | Not approved: L | HIV/AIDS |
$12,394,177 |
$25,714,627 |
| Liberia | CCM | Not approved: L | HSS |
$14,078,615 |
$17,374,573 |
| Liberia | CCM | Not approved: L | Malaria |
$15,015,748 |
$33,165,706 |
| Liberia | CCM | Not approved: L | TB |
$4,750,966 |
$11,949,773 |
| Macedonia | CCM | Provisionally approved: F | TB |
$1,442,489 |
$3,071,097 |
| Madagascar | CCM | Not approved: L | HIV/AIDS |
$9,512,412 |
$24,957,422 |
| Madagascar | CCM | Not approved: L | HSS |
$4,965,759 |
$22,599,312 |
| Madagascar | CCM | Not approved: L | Malaria |
$7,974,500 |
$33,470,801 |
| Madagascar | CCM | Not approved: L | TB |
$8,900,519 |
$15,249,703 |
| Malawi | CCM | Immediately Approved: B | HIV/AIDS |
$7,770,655 |
$19,104,775 |
| Malawi | CCM | Immediately Approved: B | HSS |
$26,965,524 |
$65,429,986 |
| Maldives | CCM | Not approved: M | HIV/AIDS |
$2,016,601 |
$4,184,665 |
| Mali | CCM | Not approved: L | HSS |
$7,083,766 |
$11,600,785 |
| Mali | CCM | Not approved: L | Malaria |
$14,862,149 |
$36,069,482 |
| Mauritania | CCM | Provisionally approved: D | HIV/AIDS |
$6,584,973 |
$15,755,931 |
| Mongolia | CCM | Provisionally approved: D | HIV/AIDS |
$1,898,775 |
$4,235,640 |
| Montenegro | CCM | Provisionally approved: F | HIV/AIDS |
$1,604,606 |
$2,924,696 |
| Mozambique | CCM | Not approved: L | HSS |
$72,100,000 |
$106,600,000 |
| Mozambique | CCM | Not approved: L | Malaria |
$32,694,480 |
$73,121,487 |
| Mozambique, South Africa, Swaziland | Regional CM | Provisionally approved: I | Malaria |
$6,501,141 |
$21,232,348 |
| Namibia | CCM | Immediately Approved: A | TB |
$7,222,753 |
$17,777,383 |
| Namibia | CCM | Not approved: L | HIV/AIDS |
$31,341,874 |
$91,950,544 |
| Namibia | CCM | Not approved: L | Malaria |
$13,136,240 |
$21,897,490 |
| Nepal | CCM | Not approved: L | HIV/AIDS |
$7,717,233 |
$25,788,007 |
| Nepal | CCM | Not approved: L | Malaria |
$5,352,822 |
$11,372,370 |
| Nepal | CCM | Not approved: L | TB |
$3,858,926 |
$9,481,273 |
| Niger | CCM | Immediately Approved: B | Malaria |
$5,148,600 |
$10,491,196 |
| Niger | CCM | Provisionally approved: D | TB |
$6,326,070 |
$12,220,815 |
| Niger | CCM | Not approved: L | HSS |
$7,529,467 |
$11,474,188 |
| Nigeria | CCM | Immediately Approved: B | HIV/AIDS |
$46,424,283 |
$180,642,512 |
| Nigeria | CCM | Immediately Approved: B | TB |
$19,217,311 |
$53,351,149 |
| Nigeria | CCM | Not approved: L | HSS |
$39,505,341 |
$64,812,236 |
| Nigeria | CCM | Not approved: L | Malaria |
$52,404,797 |
$179,995,004 |
| Pakistan | CCM | Not approved: L | HIV/AIDS |
$13,000,477 |
$34,989,566 |
| Pakistan | CCM | Not approved: L | Malaria |
$11,293,294 |
$27,059,519 |
| Pakistan | CCM | Not approved: L | TB |
$15,854,040 |
$30,308,701 |
| Pakistan | CCM | Not approved: M | HSS |
$9,977,880 |
$26,617,490 |
| Papua New Guinea | CCM | Not approved: L | TB |
$1,975,954 |
$10,784,888 |
| Paraguay | CCM | Not approved: M | HIV/AIDS |
$3,941,134 |
$9,429,262 |
| Peru | CCM | Provisionally approved: F | HIV/AIDS |
$9,874,896 |
$12,967,865 |
| Peru | CCM | Provisionally approved: F | TB |
$21,017,537 |
$32,545,545 |
| Peru | CCM | Not approved: L | HSS |
$6,894,200 |
$17,011,200 |
| Philippines | CCM | Provisionally approved: F | HIV/AIDS |
$3,011,919 |
$6,478,058 |
| Philippines | CCM | Provisionally approved: F | Malaria |
$11,097,529 |
$14,308,637 |
| Philippines | CCM | Not approved: L | TB |
$14,208,812 |
$45,817,584 |
| Republic of Congo | CCM | Provisionally approved: D | HIV/AIDS |
$12,043,407 |
$45,553,763 |
| Republic of Congo | CCM | Not approved: L | Malaria |
$17,664,123 |
$28,331,791 |
| Republic of Congo | CCM | Not approved: L | TB |
$4,669,340 |
$8,138,467 |
| Russian Federation | Non-CCM | Provisionally approved: K | HIV/AIDS |
$3,774,826 |
$12,190,713 |
| Rwanda | CCM | Immediately Approved: A | HSS |
$14,322,867 |
$33,945,080 |
| Rwanda | CCM | Immediately Approved: B | Malaria |
$28,140,772 |
$39,649,363 |
| Rwanda | CCM | Not approved: L | HIV/AIDS |
$36,053,491 |
$88,300,796 |
| Samoa, Cook Islands, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, Niue, Palau, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu | Regional Coordinating Mechanism | Not approved: L | HIV/AIDS |
$4,251,406 |
$9,946,332 |
| Samoa, Cook Islands, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, Niue, Palau, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu | Regional Coordinating Mechanism | Not approved: L | TB |
$1,466,940 |
$4,432,060 |
| Sao Tome & Principe | CCM | Provisionally approved: J | HIV/AIDS |
$584,218 |
$1,485,190 |
| Senegal | CCM | Not approved: L | TB |
$8,725,379 |
$18,336,573 |
| Senegal | CCM | Not approved: M | HSS |
$2,321,013 |
$3,384,233 |
| Senegal | CCM | Not approved: M | Malaria |
$8,251,057 |
$12,117,141 |
| Serbia | CCM | Not approved: L | HIV/AIDS |
$4,755,306 |
$8,462,528 |
| Solomon Islands, Vanuatu | Regional Coordinating Mechanism | Provisionally approved: H | Malaria |
$3,269,731 |
$6,623,560 |
| Somalia | Non-CCM | Not approved: L | HSS |
$1,175,365 |
$2,832,730 |
| Somalia | Non-CCM | Not approved: L | Malaria |
$2,567,445 |
$14,532,272 |
| South Africa | CCM | Not approved: L | HIV/AIDS |
$45,010,000 |
$108,289,000 |
| South Africa | CCM | Not approved: L | HSS |
$21,851,000 |
$42,173,000 |
| Sri Lanka | CCM | Not approved: L | Malaria |
$4,356,374 |
$7,290,124 |
| Sri Lanka | CCM | Not approved: L | TB |
$1,700,680 |
$4,414,795 |
| Sri Lanka | CCM | Not approved: M | HIV/AIDS |
$2,607,594 |
$5,357,285 |
| Sudan | CCM | Not approved: L | HIV/AIDS |
$29,424,335 |
$112,553,275 |
| Sudan | CCM | Not approved: L | Malaria |
$24,019,599 |
$46,323,995 |
| Sudan | CCM | Not approved: L | TB |
$6,830,013 |
$15,410,468 |
| Sudan | CCM | Not approved: M | HSS |
$42,800,000 |
$105,860,000 |
| Sudan (Southern Sector) | Sub-CCM | Immediately Approved: B | TB |
$8,592,197 |
$27,568,526 |
| Sudan (Southern Sector) | Sub-CCM | Not approved: L | HSS |
$25,929,249 |
$68,455,557 |
| Suriname | CCM | Provisionally approved: F | HIV/AIDS |
$2,600,000 |
$4,400,000 |
| Tajikistan | CCM | Provisionally approved: J | Malaria |
$2,772,001 |
$5,383,510 |
| Tanzania | CCM | Not approved: L | HIV/AIDS |
$9,204,276 |
$11,932,883 |
| Tanzania | CCM | Not approved: L | HSS |
$22,869,642 |
$34,866,750 |
| Tanzania Zanzibar | CCM | Not approved: L | HIV/AIDS |
$12,722,287 |
$30,817,709 |
| Thailand | CCM | Not approved: L | HIV/AIDS |
$5,920,079 |
$16,886,287 |
| The Gambia | CCM | Provisionally approved: D | TB |
$2,561,327 |
$5,032,929 |
| The Gambia | CCM | Not approved: L | HIV/AIDS |
$7,842,275 |
$14,733,869 |
| The Gambia | CCM | Not approved: L | Malaria |
$18,169,122 |
$40,473,141 |
| Tunisia | CCM | Not approved: L | HIV/AIDS |
$10,007,400 |
$20,898,000 |
| Turkey | CCM | Not approved: M | Malaria |
$2,387,990 |
$4,784,490 |
| Turkey | CCM | Not approved: M | TB |
$1,113,144 |
$1,556,804 |
| Uganda | CCM | Not approved: L | HIV/AIDS |
$5,857,397 |
$17,746,651 |
| Uganda | CCM | Not approved: L | HSS |
$5,605,994 |
$10,942,316 |
| Uganda | CCM | Not approved: L | Malaria |
$49,494,235 |
$90,219,700 |
| Vietnam | CCM | Not approved: L | HIV/AIDS |
$6,500,000 |
$20,000,000 |
| Vietnam | CCM | Not approved: L | TB |
$7,037,112 |
$18,718,344 |
| Yemen | CCM | Not approved: L | Malaria |
$15,889,956 |
$41,763,366 |
| Zambia | CCM | Not approved: L | HIV/AIDS |
$481,308,000 |
$1,033,420,000 |
| Zambia | CCM | Not approved: L | HSS |
$11,042,000 |
$34,940,000 |
| Zambia | CCM | Not approved: L | Malaria |
$22,147,000 |
$41,200,000 |
| Zambia | CCM | Not approved: L | TB |
$98,610,000 |
$246,525,000 |
| Zimbabwe | CCM | Immediately Approved: B | HIV/AIDS |
$35,931,159 |
$62,478,891 |
| Zimbabwe | CCM | Immediately Approved: B | Malaria |
$21,217,469 |
$29,998,400 |
| Zimbabwe | CCM | Immediately Approved: B | TB |
$10,087,276 |
$13,471,926 |
Information on Round 5 grants is also available on the Global Fund web site at www.theglobalfund.org/en/about/board/eleventh.
An applicant may appeal the board's decision if the applicant submitted an eligible proposal for a particular component in both Round 4 and Round 5 and was not approved in either case. The appeal must show that the recommendation made by the TRP regarding the Round 5 proposal was based on a "significant and obvious" error. The appeal must be filed with the Secretariat no later than 28 days from when the applicant receives written notice of the board's Round 5 decision. For further details regarding the appeals procedure, see www.theglobalfund.org/en/apply/proposals/appeals.
